Syndax Pharmaceuticals (SNDX) Misses Q4 EPS by 3c; Provides Q1 & FY19 Operating Guidance

Go back to Syndax Pharmaceuticals (SNDX) Misses Q4 EPS by 3c; Provides Q1 & FY19 Operating Guidance
(NASDAQ: SNDX) Delayed: 19.61 +0.29 (1.50%)
Previous Close $19.32    52 Week High $18.03 
Open $19.32    52 Week Low $8.97 
Day High $20.00    P/E N/A 
Day Low $19.21    EPS $0.00 
Volume 1,015,623